Matches in SemOpenAlex for { <https://semopenalex.org/work/W2410005441> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W2410005441 endingPage "15" @default.
- W2410005441 startingPage "1009" @default.
- W2410005441 abstract "Previous studies have examined medication use among patients with coronary artery disease who have suffered an acute myocardial infarction (MI). However, little is known about medication use among patients with coronary artery disease who undergo percutaneous coronary intervention (PCI).To examine the patterns of use of medical therapy among patients who undergo PCI; and to examine the determinants of medical therapy in these patients.The Routine versus Selective Exercise Treadmill Testing after Angioplasty (ROSETTA) registry is a prospective multicentre study examining the use of functional testing after PCI. The medication use was examined among 787 patients who were enrolled in the ROSETTA registry at 13 clinical centres in five countries.Most patients were men (mean age 61+/-11 years, 76% male) who underwent single vessel PCI (85%) with stent implantation (58%). At admission, discharge and six months, rates of acetylsalicylic acid use were 77%, 96% and 93%, respectively (discharge versus six months, P<0.0001). Rates of use of other oral antiplatelet agents were 11%, 59% and 2% (P=0.02). For individual anti-ischemic medications, rates of use were as follows: beta-blockers 49%, 58% and 59% (P<0.0001); calcium antagonists 34%, 43% and 42% (P<0.0001); and nitrates 42%, 56% and 43% (P<0.0001). Rates of use of combination anti-ischemic medications were as follows: triple therapy 7%, 9% and 9% (P<0.0001); double therapy 34%, 47% and 38% (P<0.0001); monotherapy 36%, 36% and 41% (P<0.0001); and no anti-ischemic therapy 23%, 8% and 12% (P<0.0001). Rates of use of angiotensin-converting enzyme inhibitors were 25%, 33% and 32% (P<0.0001), and rates of use of lipid lowering agents were 41%, 52% and 61% (P<0.0001).Trials and guidelines statements have favourably affected the rates of use of acetylsalicylic acid and other antiplatelet agents after PCI. However, in spite of patients undergoing a successful revascularization procedure, physicians do not reduce the use of anti-ischemic medical therapy." @default.
- W2410005441 created "2016-06-24" @default.
- W2410005441 creator A5017235084 @default.
- W2410005441 creator A5020886020 @default.
- W2410005441 creator A5026218027 @default.
- W2410005441 creator A5041357908 @default.
- W2410005441 creator A5044651487 @default.
- W2410005441 creator A5045302681 @default.
- W2410005441 creator A5049468337 @default.
- W2410005441 creator A5054375345 @default.
- W2410005441 creator A5056291985 @default.
- W2410005441 creator A5060582396 @default.
- W2410005441 creator A5064482802 @default.
- W2410005441 creator A5072116483 @default.
- W2410005441 creator A5083391077 @default.
- W2410005441 creator A5087193363 @default.
- W2410005441 date "2003-08-01" @default.
- W2410005441 modified "2023-09-27" @default.
- W2410005441 title "Medical therapy in patients undergoing percutaneous coronary intervention: results from the ROSETTA registry." @default.
- W2410005441 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12915928" @default.
- W2410005441 hasPublicationYear "2003" @default.
- W2410005441 type Work @default.
- W2410005441 sameAs 2410005441 @default.
- W2410005441 citedByCount "4" @default.
- W2410005441 countsByYear W24100054412016 @default.
- W2410005441 countsByYear W24100054412017 @default.
- W2410005441 crossrefType "journal-article" @default.
- W2410005441 hasAuthorship W2410005441A5017235084 @default.
- W2410005441 hasAuthorship W2410005441A5020886020 @default.
- W2410005441 hasAuthorship W2410005441A5026218027 @default.
- W2410005441 hasAuthorship W2410005441A5041357908 @default.
- W2410005441 hasAuthorship W2410005441A5044651487 @default.
- W2410005441 hasAuthorship W2410005441A5045302681 @default.
- W2410005441 hasAuthorship W2410005441A5049468337 @default.
- W2410005441 hasAuthorship W2410005441A5054375345 @default.
- W2410005441 hasAuthorship W2410005441A5056291985 @default.
- W2410005441 hasAuthorship W2410005441A5060582396 @default.
- W2410005441 hasAuthorship W2410005441A5064482802 @default.
- W2410005441 hasAuthorship W2410005441A5072116483 @default.
- W2410005441 hasAuthorship W2410005441A5083391077 @default.
- W2410005441 hasAuthorship W2410005441A5087193363 @default.
- W2410005441 hasConcept C126322002 @default.
- W2410005441 hasConcept C141071460 @default.
- W2410005441 hasConcept C164705383 @default.
- W2410005441 hasConcept C2778213512 @default.
- W2410005441 hasConcept C2780326628 @default.
- W2410005441 hasConcept C2780400711 @default.
- W2410005441 hasConcept C45393284 @default.
- W2410005441 hasConcept C500558357 @default.
- W2410005441 hasConcept C71924100 @default.
- W2410005441 hasConceptScore W2410005441C126322002 @default.
- W2410005441 hasConceptScore W2410005441C141071460 @default.
- W2410005441 hasConceptScore W2410005441C164705383 @default.
- W2410005441 hasConceptScore W2410005441C2778213512 @default.
- W2410005441 hasConceptScore W2410005441C2780326628 @default.
- W2410005441 hasConceptScore W2410005441C2780400711 @default.
- W2410005441 hasConceptScore W2410005441C45393284 @default.
- W2410005441 hasConceptScore W2410005441C500558357 @default.
- W2410005441 hasConceptScore W2410005441C71924100 @default.
- W2410005441 hasIssue "9" @default.
- W2410005441 hasLocation W24100054411 @default.
- W2410005441 hasOpenAccess W2410005441 @default.
- W2410005441 hasPrimaryLocation W24100054411 @default.
- W2410005441 hasRelatedWork W1506200166 @default.
- W2410005441 hasRelatedWork W1969111604 @default.
- W2410005441 hasRelatedWork W2080531066 @default.
- W2410005441 hasRelatedWork W2259263735 @default.
- W2410005441 hasRelatedWork W2321561256 @default.
- W2410005441 hasRelatedWork W2418573861 @default.
- W2410005441 hasRelatedWork W2748952813 @default.
- W2410005441 hasRelatedWork W2789448498 @default.
- W2410005441 hasRelatedWork W2899084033 @default.
- W2410005441 hasRelatedWork W4213006514 @default.
- W2410005441 hasVolume "19" @default.
- W2410005441 isParatext "false" @default.
- W2410005441 isRetracted "false" @default.
- W2410005441 magId "2410005441" @default.
- W2410005441 workType "article" @default.